ArticleBritish journal of haematology2025
Transformation and causes of death in follicular lymphoma: A Finnish nationwide population-based study.
Article in British journal of haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Canadian Hematology Consensus Group Recommendations for the Management of Relapsed and/or Refractory Follicular Lymphoma.Current oncology (Toronto, Ont.) · 2026Review
- The progression at 24 months (POD24) induces a high risk of transformation of follicular lymphoma: A systematic biopsy verification.British journal of haematology · 2026Article
- Transformation and causes of death in follicular lymphoma: A Finnish nationwide population-based study.British journal of haematology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Follicular lymphoma (FL) is a common, indolent lymphoma, and patients with FL typically have a good prognosis. However, they may experience histological transformation into aggressive large B-cell lymphoma. We conducted a nationwide population-based study to estimate the risk of transformation in FL, considering different FL grades, and studied the relative survival (RS) of patients diagnosed with FL in Finland from 1995 to 2018. We identified a total of 4014 patients with newly diagnosed grade 1-3A FL. The median age at diagnosis was 64 years, and 55% of patients were female. The cumulative incidence of transformation across the entire cohort was 8.4% at 10 years (95% confidence interval [CI], 7.5-9.5). The 10-year RS was 78% for the whole cohort and showed improvement over time. Transformation was associated with a significantly increased risk of death (hazard ratio [HR] 5.0; 95% CI, 4.2-6.0; p < 0.001). Grade 3A was associated with higher excess mortality compared to patients with low-grade FL. Lymphoma was the most common cause of death. We conclude that, although the 10-year RS was relatively good, grade 3A FL and transformation led to significantly higher mortality compared to low-grade FL or no transformation. Our results also indicate a reduction in excess mortality over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.